Jane Street’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-13,041
| Closed | -$197K | – | 10791 |
|
|
2022
Q3 | $197K | Sell |
13,041
-43,422
| -77% | -$505K | ﹤0.01% | 8196 |
|
|
2022
Q2 | $423K | Buy |
+56,463
| New | +$398K | ﹤0.01% | 7032 |
|
|
2022
Q1 | – | Sell |
-62,058
| Closed | -$436K | – | 11390 |
|
|
2021
Q4 | $436K | Buy |
62,058
+51,804
| +505% | +$542K | ﹤0.01% | 7507 |
|
|
2021
Q3 | $117K | Buy |
+10,254
| New | +$150K | ﹤0.01% | 9209 |
|
|
2021
Q2 | – | Sell |
-13,893
| Closed | -$249K | – | 10711 |
|
|
2021
Q1 | $249K | Sell |
13,893
-27,162
| -66% | -$469K | ﹤0.01% | 7955 |
|
|
2020
Q4 | $555K | Buy |
+41,055
| New | +$496K | ﹤0.01% | 5576 |
|
|
2020
Q3 | – | Sell |
-29,115
| Closed | -$355K | – | 8215 |
|
|
2020
Q2 | $430K | Buy |
+29,115
| New | +$431K | ﹤0.01% | 5307 |
|
|
2020
Q1 | – | Sell |
-30,896
| Closed | -$747K | – | 6208 |
|
|
2019
Q4 | $747K | Buy |
+30,896
| New | +$640K | ﹤0.01% | 3175 |
|
|
2018
Q4 | – | Sell |
-4,433
| Closed | -$273K | – | 5975 |
|
|
2018
Q3 | $273K | Buy |
+4,433
| New | +$285K | ﹤0.01% | 4329 |
|
|
2018
Q1 | – | Sell |
-9,966
| Closed | -$595K | – | 5612 |
|
|
2017
Q4 | $595K | Buy |
9,966
+5,237
| +111% | +$318K | ﹤0.01% | 2980 |
|
|
2017
Q3 | $230K | Buy |
+4,729
| New | +$258K | ﹤0.01% | 3989 |
|
|
2016
Q4 | – | Sell |
-48,018
| Closed | -$1.81M | – | 4779 |
|
|
2016
Q3 | $1.81M | Buy |
+48,018
| New | +$1.06M | 0.01% | 1302 |
|
|
2016
Q1 | – | Sell |
-21,286
| Closed | -$518K | – | 4796 |
|
|
2015
Q4 | $518K | Buy |
21,286
+9,784
| +85% | +$228K | ﹤0.01% | 2447 |
|
|
2015
Q3 | $204K | Buy |
+11,502
| New | +$208K | ﹤0.01% | 3173 |
|
|
2015
Q2 | – | Sell |
-11,606
| Closed | -$364K | – | 4181 |
|
|
2015
Q1 | $364K | Buy |
+11,606
| New | +$336K | ﹤0.01% | 2346 |
|
|
2014
Q3 | – | Sell |
-9,338
| Closed | -$231K | – | 3212 |
|
|
2014
Q2 | $231K | Buy |
+9,338
| New | +$162K | ﹤0.01% | 2078 |
|
Jane Street's AERI Position: Q4 2022 in Review
Jane Street sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 13,041 shares — an estimated $197K sold.
Jane Street first reported a position in AERI in Q2 2014 and held it in 16 quarters. The position peaked at $1.81M in Q3 2016. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Jane Street reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Jane Street sold 13,041 Aerie Pharmaceuticals shares in Q4 2022, an estimated $197K.
- Jane Street first reported a position in Aerie Pharmaceuticals in Q2 2014 and held it in 16 quarters.
- Jane Street's Aerie Pharmaceuticals position peaked at $1.81M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.